Atlas Trials

Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas

Clinical trial NCT06346197 · RECRUITING

Trial details

NCT number
NCT06346197
Sponsor
Centre Leon Berard
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Gastric CancerMSI-HMetastatic CancerAdvanced Cancer
Start date
2025-12-08
Primary completion
2028-05-15
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.